BCN PEPTIDES SA

Overview

BCN PEPTIDES SA is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering ANGIOTENSIN II; CETRORELIX; DESMOPRESSIN ACETATE; GANIRELIX ACETATE; ICATIBANT ACETATE; LANREOTIDE.

API / Drug Master Files

BCN PEPTIDES SA holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LANREOTIDEActive2023-12-21
• CETRORELIXActive2023-03-31
• ANGIOTENSIN IIActive2021-10-04
• GANIRELIX ACETATEActive2015-07-24
• ICATIBANT ACETATEActive2015-03-26
• LEUPROLIDE (LEUPRORELIN)Active2012-12-11
• NESIRITIDEActive2012-12-04
• VASOPRESSINActive2012-01-24
• SALMON CALCITONINActive2006-07-05
• DESMOPRESSIN ACETATEActive2006-04-06
• TETRACOSACTIDEActive2005-11-18
• OCTREOTIDE ACETATEActive2005-09-08

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BCN PEPTIDES SA in our records. PharmaTek screens the full directory against live FDA enforcement data.